In vivo evolution of tumor-derived endothelial cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  McGuire, Terence F ^a   Sajithlal, Gangadharan B ^a   Lu, Jie ^a   Nicholls, Robert D ^a,b,d   Prochownik, Edward V ^a,c,d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CANCER INHIBITION; CELL CLONING; CELL EXPANSION; CELL FUNCTION; CHROMOSOME LOSS; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EVOLUTION; GENE EXPRESSION; GENETIC GAIN; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL; TUMOR DERIVED ENDOTHELIAL CELL; TUMOR VASCULARIZATION; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VASCULARIZATION;

CELL DIFFERENTIATION; CELL LINEAGE; CYTOGENETIC ANALYSIS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84862110799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037138     Document Type: Article

References (55)

1. Baeriswyl V, Christofori G, (2009) The angiogenic switch in carcinogenesis. Semin Cancer Biol 9: 329-337.
2. Folkman J, (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
3. Folkman J, (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29 (6 Suppl 16): 15-18.
4. Nyberg P, Salo T, Kalluri R, (2008) Tumor microenvironment and angiogenesis. Front Biosci 13: 6537-6553.
5. Almog N, (2010) Molecular mechanisms underlying tumor dormancy. Cancer Lett 294: 139-146.
6. Naumov GN, Akslen LA, Folkman J, (2006) Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5: 1779-1787.
7. Dome B, Dobos J, Tovari J, Paku S, Kovacs G, et al. (2008) Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 73: 186-193.
8. Larrivee B, Karsan A, (2007) Involvement of marrow-derived endothelial cells in vascularization. Handb Exp Pharmacol 180: 89-114.
9. Kopp HG, Ramos CA, Rafii S, (2006) Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 13: 175-181.
10. Abdelrahim M, Konduri S, Basha R, Philip PA, Baker CH, (2010) Angiogenesis: an update and potential drug approaches. Int J Oncol 36: 5-18.
11. Cao Y, (2009) Tumor angiogenesis and molecular targets for therapy. Front Biosci 14: 3962-3973.
12. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
13. Jenab-Wolcott J, Giantonio BJ, (2009) Bevacizumab: current indications and future development for management of solid tumors. Expert Opin Biol Ther 9: 507-517.
14. Tonra JR, Hicklin DJ, (2007) Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. Immunol Invest 36: 3-23.
15. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, et al. (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349: 427-434.
16. Sajithlal GB, McGuire, TF, Lu, J, Beer-Stolz, D, Prochownik, EV, (2010) Endothelial-like cells derived directly from human tumor xenografts. Int. J. Cancer 127: 2268-2278.
17. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-828.
18. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833.
19. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, et al. (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246-255.
20. Paulis YW, Soetekouw PM, Verheul HM, Tjan-Heijnen VC, Griffioen AW, (2010) Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta 1806 18-28 pp. 18-28.
21. Lawley TJ, Kubota Y, (1989) Induction of morphologic differentiation of endothelial cells in culture. The J Invest Dermatol 93(2 Suppl) pp. 59S-61S.
22. Shakado S, Sakisaka S, Noguchi K, Yoshitake M, Harada M, et al. (1995) Effects of extracellular matrices on tube formation of cultured rat hepatic sinusoidal endothelial cells. Hepatology 22: 969-973.
23. Bottos A, Destro E, Rissone A, Graziano S, Cordara G, et al. (2009) The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions. Proc Natl Acad Sci U S A 106 (49): 20782-20787.
24. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, et al. (2010) Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS ONE 5: e9201.
25. Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, et al. (2010) Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 70: 160-171.
26. Kolosionek E, Savai R, Ghofrani HA, Weissmann N, Guenther A, et al. (2009) Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Mol Biol Cell 20: 4751-4765.
27. Schluter OM, Khvotchev M, Jahn R, Südhof TC, (2002) Localization versus function of Rab3 proteins. Evidence for a common regulatory role in controlling fusion. J Biol Chem 277: 40919-40929.
28. Johannsdottir HK, Jonsson G, Johannesdottir G, Agnarsson BA, Eerola H, et al. (2006) Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors. Int J Cancer 119: 1052-1060.
29. Tamura K, Makino A, Hullin-Matsuda F, Kobayashi T, Furihata M, et al. (2009) Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res 69: 8133-8140.
30. Fousteri M, Mullenders LH, (2008) Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res 18: 73-84.
31. Zhou XH, Brandau O, Feng K, Oohashi T, Ninomiya Y, et al. (2003) The murine Ten-m/Odz genes show distinct but overlapping expression patterns during development and in adult brain. Gene Expr Patterns 3: 397-405.
32. Vinatzer U, Gollinger M, Müllauer L, Raderer M, Chott A, et al. (2008) Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res 14: 6426-6431.
33. Haines BP, Rigby PW, (2008) Expression of the Lingo/LERN gene family during mouse embryogenesis. Gene Expr Patterns 8: 79-86.
34. Zhang D, Jiang P, Xu Q, Zhang X, (2011) Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth. J Biol Chem 286: 17746-17754.
35. Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD, (2010) Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J Cell Sci 123: 1235-1246.
36. Schildkraut JM, Iversen ES, Wilson MA, Clyde MA, Moorman PG, et al. (2010) Association between DNA damage resonse and repair genes and risk of invasive serous ovarian cancer. PLoS ONE 5 (4): e10061.
37. Chen D, Vollmar M, Rossi MN, Phillips C, Kraehenbuehl R, et al. (2011) Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J Biol Chem 286: 13261-13271.
38. Davison EJ, Tarpey PS, Fiegler H, Tomlinson IP, Carter NP, (2005) Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization. Gene Chromosomes Cancer 44: 384-391.
39. Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, et al. (2004) Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 64: 7231-7236.
40. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, et al. (2004) Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
41. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, et al. (2001) Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 10: 1907-1913.
42. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, et al. (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60: 2562-2566.
43. Paterson RF, Ulbright TM, MacLennan GT, Zhang S, Pan CX, et al. (2003) Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 98: 1830-1836.
44. Pelham RJ, Rodgers L, Hall I, Lucito R, Nguyen KC, et al. (2006) Identification of alterations in DNA copy number in host stromal cells during tumor progression. Proc Natl Acad Sci USA 103: 19848-19853.
45. Streubel B, Chott A, Huber D, Exner M, Jäger U, et al. (2004) Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351: 250-259.
46. Bussolati B, Grange C, Sapino A, Camussi G, (2009) Endothelial cell differentiation of human breast tumour stem/progenitor cells. J Cell Mol Med 13: 309-319.
47. Creighton CJ, Chang JC, Rosen JM, (2010) Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 15: 253-260.
48. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
49. Yang J, Weinberg RA, (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
50. Adams RH, Eichmann A, (2010) Axon guidance molecules in vascular patterning. Cold Spring Harbor perspectives in biology. Cold Spring Harbor Laboratory Press 2: a001875.
51. Larrivee B, Freitas C, Suchting S, Brunet I, Eichmann A, (2009) Guidance of vascular development: lessons from the nervous system. Circ Res 104: 428-441.
52. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ, (2002) Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109: 693-705.
53. Mukouyama YS, Gerber HP, Ferrara N, Gu C, Anderson DJ, (2005) Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132: 941-952.
54. Carmeliet P, Tessier-Lavigne M, (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436: 193-200.
55. Suckow AT, Comoletti D, Waldrop MA, Mosedale M, Egodage S, et al. (2008) Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic β-cells and the involvement of neuroligin in insulin secretion. Endocrinology 149: 6006-6017.